From Hong Kong to the World: Terragene Advances Evidence-Based Sterilization
Terragene’s participation at the World Sterilization Congress 2025 in Hong Kong marked a new milestone in its mission to bring science-based innovation to every sterilization center in the world.
Terragene team at Booth D04, World Sterilization Congress 2025, Hong Kong
At Booth D04, hundreds of professionals from the Asia-Pacific region experienced live demonstrations of Photon®, Hyper®, PRO1 Micro®, and PRO1 Endo® — technologies that are transforming hospital sterilization through measurable evidence and real-time control.
The scientific symposium “From Assumption to Evidence: Quantitative Protein Testing in CSSDs”, led by Drs. Antonela Sdrigotti, inspired specialists from across the globe to rethink cleaning verification practices.
Her presentation emphasized the importance of testing and proving as key elements in ensuring patient safety and driving sustainable reprocessing.
“Testing is not the future — it’s the present.
Science connects us. Evidence transforms us.”
With the support of Terragene’s Asia-Pacific team — Yining, SG Lee, Azrul, and Risma Lia — the company reinforced its global presence and its vision of a connected, sustainable future for hospital sterilization.
💡 Terragene continues to lead the industry with one clear purpose:
To move from assumptions to evidence, and from evidence to transformation.
Need a Terragene partner in your region?
We’ll guide you — click here & contact us